Is Machine Translation a Viable Option for COA Translation?
Learn when AI-driven solutions are viable and how they compare to traditional methods....
Learn when AI-driven solutions are viable and how they compare to traditional methods....
In this episode of LifeSci Talks, TransPerfect Life Sciences’ Global Practice Leader Mark Wade sits down with Kelly Dumais PhD, Director of eCOA Science at Clario to discuss the significance rater training plays in standardizing the administration and scoring of clinical scales. Aiming to reduce bias and enhance data quality, you’ll hear about potential strategies for better engaging patients and how comprehensive proactive training can reduce patient and site burden. Listen...
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO of THREAD research to discuss the importance of patient listening to build better clinical trial endpoints. They delve into the differences between enterprise and standalone solutions, challenges with standardization, and the influence of evolving technologies in the eCOA industry. ...
Content automation technologies have been developing for 70 years – MDR and IVDR have accelerated this development, as well as adoption across the device industry. And, while product-related applications for artificial intelligence (AI) generate attention-grabbing headlines, the larger (and more certain) financial benefits are in process-related applications. So the question remains: How are translation AI and process automation software (CCMS, TMS) converging to automate...
In this episode of LifeSci Talks, TransPerfect’s Global Practice Leader Mark Wade sits down with Dr. Karl McEvoy, VP of eCOA and Patient Technology at YPrime, to discuss the importance of embracing technology in clinical research to reduce the patient burden. The two cover everything from updating legacy instruments to more modern solutions such as using video assessments, to incorporating caregiver and patient advocacy groups input for reshaping trial design. Listen in for...
The European Union's introduction of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) marks a significant shift towards enhanced transparency in the medical device sector. While these regulations are designed to strengthen patient safety following several high-profile device failures, they have also created complex labeling updates and post market reporting requirements. Medical device companies must now navigate these complexities...
Accurate and compliant labeling of an investigational medicinal product (IMP) is an important and integral part of clinical trial operations. A misstep in labeling can lead to significant delays, affecting the entire study’s timeline and potentially incurring costs ranging from $100,000 to $700,000 in hard expenses. In worst-case scenarios, incorrect labeling might necessitate a complete product reproduction. Learn more about the strategies and solutions leading sponsors are...
With an ambitious global rollout deadline and limited internal bandwidth, this top 10 pharma company needed a smarter way to scale localization. Learn how automation and streamlined workflows helped transform the candidate experience across 15 markets, without slowing down speed to launch....
In an increasingly globalized digital landscape, the demand for personalized content has never been greater. Listen as Joy Wendelken from Johnson & Johnson alongside Sara Green of WebMD Ignite in conversation with Dana Weber from TransPerfect Digital discuss how omnichannel marketing is helping pharma companies better engage and more effectively reach patients and HCPs. You’ll hear about: • The importance (and challenges) of tailoring content in an era of information...
The global clinical landscape is becoming more complex every day, with evolving regulations and increased pressure on life sciences organizations to reduce costs and timelines. Join us for an in-depth discussion on how one of the world’s leading pharma companies is leveraging AI to enhance their translation processes, quality, and globalization strategy across internal departments. From integrations between cloud-based translation systems and regulatory platforms to...
The rapid rise of artificial intelligence presents an opportunity for effective and transformative applications in pharmacovigilance. Intake, query routing and response, case reporting, HAQs, and more are now extremely feasible use cases that create exponential efficiency in reducing costs, administrative burden, and timelines while increasing quality and, most importantly, improving safety....
TransPerfect supports the development of the Global Learning Program: Partner4Better, by delivering relevant educational content to a global audience in diverse languages....
Navigating the complexities of global healthcare campaigns requires a well-balanced mix of technology and human touch. In this webinar, TransPerfect welcomes back Krista Goedel, Clinical Digital Content Lead along with colleague Lyly Fong, Global Corporate Website Manager at Sanofi, who will discuss how AI-driven content creation, combined with human expertise and oversight, is transforming global campaigns. Gain insights into how Sanofi uses GlobalLink to maintain brand...
Life sciences organizations are facing increasing pressure to deliver accurate, compliant content across multiple channels and global markets faster than ever. To keep pace, many are turning to Structured or Component Content Management Systems (SCMS/CCMS), which allow teams to build content in modular, reusable components, rather than relying on static, document-based workflows. This modern approach makes it easier to link, version, and repurpose content across formats,...
Medical device companies are leveraging artificial intelligence and machine learning to streamline regulated medical device content work streams, including labeling, marketing, and PMS reporting. Learn about implementing a strategic AI program and discover how top medical device companies save time and cut costs with AI-powered translation and localization in this guide. ...
As artificial intelligence continues to change the way pharma companies engage with patients globally, a critical question emerges: how do we ensure patients remain at the heart of clinical research? In this webinar with Innovative Trials, SOGLIA, Subjectwell, and Pleco Therapeutics, you’ll learn about the current landscape and future outlook of shaping patient-centric AI to enhance global recruitment efforts. Join us to hear from industry experts as they share real-world...
In today’s evolving healthcare landscape, the role of medical affairs has been undergoing a transformation from a supportive function to a key strategic player. This shift is prompting medical teams to explore digital innovations and offer efficiencies with scaled practices. ...
Pharmaceutical companies face stringent compliance requirements and tight deadlines for reporting safety cases throughout clinical research and development. To protect patient safety and avoid penalties from regulatory authorities, pharmacovigilance teams must submit in-language reports on time. AI technology offers transformative solutions to these challenges and opens the door for increased efficiencies throughout event observation, detection, and monitoring. This guide...
Clinical trial recruitment is a complex process that requires strategic planning and data-driven decision-making. Use these AI-powered prompts to refine your approach and enhance participant engagement....
Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching the systems to analyze information and improve processes. This is done through data annotation. Discover immediate steps to leverage the power of AI/ML and easy solutions to get you started in this...
Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. Moreover, while AI offers unprecedented opportunities for increased efficiency, accuracy and quality, it also requires a strong foundation of structured data and an awareness of global regulatory...